# Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALL

> **NCT05578378** · PHASE2,PHASE3 · UNKNOWN · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 32 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** Cladribine
- **DRUG:** Fludarabine

## Key facts

- **NCT ID:** NCT05578378
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2022-10-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05578378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05578378, "Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALL". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05578378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*